CERIUM PHARMACEUTICALS, INC.

Profile

Company Names

CERIUM PHARMACEUTICALS, INC.

Addresses

312 MAIN STREET, SUITE 200, GAITHERSBURG, MD 20878

846 STILL CREEK LANE, GAITHERSBURG, MD 20878

Phone Numbers

3019632400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$13,079,113.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-07-22 
$8,900,000.00 
$10,052,959.00 
$1,152,959.00 
Equity 
2
2021-03-26 
$1,905,432.00 
$1,905,432.00 
$0.00 
Debt 
1
2016-06-13 
$2,273,681.00 
$7,273,674.00 
$4,999,993.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
THOMAS 
A 
DEPASQUALE 
DIRECTOR
RIDERCHARGE INC   |  RIDECHARGE INC   |  CERIUM PHARMACEUTICALS, INC.
JAMES 
 
GALE 
DIRECTOR
PFENEX INC.   |  IGI LABORATORIES, INC   |  ABC PHARMA ACQUISITION CO   |  BION PHARMACEUTICALS INC.   |  BIONPHARMA INC.   |  PHARMACEUTICS INTERNATIONAL, INC.   |  APICORE INC.   |  CERIUM PHARMACEUTICALS, INC.   |  ASCENDIA PHARMACEUTICALS, INC.
NANCY 
 
KLETT 
EXECUTIVE OFFICER
CERIUM PHARMACEUTICALS, INC.
GREGG 
 
LAPOINTE 
EXECUTIVE OFFICER, DIRECTOR
CERIUM PHARMACEUTICALS, INC.   |  CATABASIS PHARMACEUTICALS INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-07-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-07-22 
2021-05-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-03-26 
2016-06-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-06-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#